
Omapatrilat
CAS No. 167305-00-2
Omapatrilat ( BMS-186716 )
产品货号. M12553 CAS No. 167305-00-2
金属蛋白酶 ACE 和 NEP 的有效双重抑制剂,Ki 分别为 0.64 nM 和 0.45 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥664 | 有现货 |
![]() ![]() |
50MG | ¥4609 | 有现货 |
![]() ![]() |
100MG | ¥8068 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Omapatrilat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述金属蛋白酶 ACE 和 NEP 的有效双重抑制剂,Ki 分别为 0.64 nM 和 0.45 nM。
-
产品描述A potent, dual inhibitor of the metalloproteases ACE and NEP with Ki of 0.64 nM and 0.45 nM, respectively; shows moderate activity against APP, and low activity against ECE1; causes significant inhibition of plasma ACE and increases plasma renin activity, reduces blood pressure in spontaneously hypertensive rats; orally active.Hypertension Discontinued.
-
体外实验Omapatrilat exhibits high potency for NEP, NEP2 and ACE, moderate strong activity against APP, but low activity against ECE1 (Ki=0.45, 25, 0.64, 250 nM) . In vitro autoradiography using the specific NEP inhibitor radioligand 125I-RB104 and the specific ACE inhibitor radioligand 125I-MK351A show omapatril at (10 mg/kg) causes rapid and potent inhibition of renal NEP and ACE, respectively, for 24 h.
-
体内实验Omapatrilat demonstrates excellent blood pressure lowering in a variety of animal models characterized by various levels of plasma renin activity and significantly potentiates urinary sodium, ANP, and cGMP excretion in a cynomolgus monkey assay. Omapatrilat decreases mean arterial pressure (MAP) approximately 40 mmHg below baseline from 10 to 24 h. Oral administration of omapatrilat at 100 μM/kg once daily results in a 38 mmHg decrease in systolic blood pressure at day three as compared to vehicle . Omapatrilat is widely used in experimental protocols related to hypertension and heart failure. Chronic oral administration of omapatrilat reduces aortic leakiness and atheroma formation with enhanced endothelial independent vasorelaxation to ANP. Omapatrilat causes significant inhibition of plasma ACE and increased plasma renin activity in rats.
-
同义词BMS-186716
-
通路Metabolic Enzyme/Protease
-
靶点ACE
-
受体ACE
-
研究领域Cardiovascular Disease
-
适应症Hypertension
化学信息
-
CAS Number167305-00-2
-
分子量408.5349
-
分子式C19H24N2O4S2
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 31 mg/mL
-
SMILESO=C([C@@H]1CCC[C@](N21)([H])SCC[C@H](NC([C@@H](S)CC3=CC=CC=C3)=O)C2=O)O
-
化学全称7H-Pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid, octahydro-4-[[(2S)-2-mercapto-1-oxo-3-phenylpropyl]amino]-5-oxo-, (4S,7S,10aS)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Robl JA, et al. J Med Chem. 1997 May 23;40(11):1570-7.
2. Fryer RM, et al. Br J Pharmacol. 2008 Mar;153(5):947-55.
3. Burrell LM, et al. Am J Hypertens. 2000 Oct;13(10):1110-6.
产品手册




关联产品
-
Abz-FR-K(Dnp)-P-OH
Excellent angiotensin I-converting enzyme (ACE) substrate with a Km value of 4.0 μM and a kcat value of 210s-1.
-
H-Ile-Pro-Pro-OH
H-Ile-Pro-Pro-OH, a milk-derived peptide, inhibits angiotensin-converting enzyme (ACE) with an IC50 of 5 μM.
-
Temocaprilat
Temocaprilat 是一种血管紧张素转换酶 (ACE) 抑制剂。